A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy

被引：0
|
作者：
Shamim Ahmed Shamim
Naresh Kumar
Geetanjali Arora
Sahil Jaswal
Shivanand Shalimar
Chandrasekhar Gamanagatti
机构：
[1] All India Institute of Medical Sciences (AIIMS),Department of Nuclear Medicine
[2] AIIMS,Department of Gastroenterology and Human Nutrition
[3] AIIMS,Department of Radiodiagnosis
来源：
Annals of Nuclear Medicine | 2024年 / 38卷
关键词：
Hepatocellular carcinoma (HCC); PSMA; SUV; Ga-PSMA PET/CT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 111
页数：8
相关论文
共 50 条
  • [1] A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy
    Shamim, Shamim Ahmed
    Kumar, Naresh
    Arora, Geetanjali
    Jaswal, Sahil
    Shalimar, Shivanand
    Gamanagatti, Shivanand
    Bal, Chandrasekhar
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (02) : 103 - 111
  • [2] Value of post-therapy 177Lu-PSMA images for accurate interpretation of therapy response with 68Ga-PSMA PET/CT
    Tuncel, M.
    Telli, T.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 114 - 117
  • [3] Evaluation of combined or separate automatic segmentation models for 68Ga-PSMA PET/CT and 177Lu-PSMA SPECT/CT
    Decazes, P.
    Perret, S.
    Albe, L.
    Tonnelet, D.
    Mesbah, Z.
    Modzelewski, R.
    Bohn, P.
    Vera, P.
    Edet-Sanson, A.
    Dieudonne, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S776 - S776
  • [4] Exceptional Response of Rare Plasmacytoid Variant Prostate Cancer Post 177Lu-PSMA Therapy Seen on 68Ga-PSMA PET/CT
    Maharaj, Masha
    Heslop, Lucille
    Govender, Trisha
    Korowlay, Nisaar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (02) : E69 - E70
  • [5] PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy
    Hartrampf, Philipp E.
    Serfling, Sebastian E.
    Michalski, Kerstin
    Buck, Andreas K.
    Werner, Rudolf A.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 69 - 76
  • [6] Utility of 18F-FDG AND 68Ga-PSMA PET/CT prior to 177Lu-PSMA radioligand therapy in metastatic castration resistant prostate cancer: A prospective study
    Babu, A. S.
    Jaleel, J.
    Khan, D.
    Yadav, M. P.
    Ballal, S.
    Tripathi, M.
    Sagar, S.
    Sahoo, R. K.
    Bal, C. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S504 - S504
  • [7] 68Ga-PSMA PET/CT Imaging in Multiple Myeloma
    Sasikumar, Arun
    Joy, Ajith
    Pillai, M. R. A.
    Nanabala, Raviteja
    Thomas, Boben
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (02) : E126 - E127
  • [8] 68Ga-PSMA and 177Lu-PSMA of high specific activity for targeted diagnosis and therapy of prostate cancer in patients
    Bentancor, Natali
    Trindade, Victoria
    Vasilskis, Elena
    Sanz, Inas
    Balter, Henia
    Engler, Henry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [9] Deep learning for 177Lu-PSMA dose prediction from pre-therapeutic 68Ga-PSMA PET/CT radiomics features
    Balaji, Vibha
    Yang, Fan
    Lei, Bowen
    Luo, Jie
    Heidari, Pedram
    Li, Quanzheng
    Dutta, Joyita
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [10] Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters
    Aksu, Aysegul
    Topuz, Ozge Vural
    Yilmaz, Burcak
    Sen, Nazli Pinar Karahan
    Acar, Emine
    Kaya, Gamze Capa
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (04) : 468 - 474
12345